Background {#Sec1}
==========

Congenital heart diseases (CHD) include a variety of malformations of the heart and major vessels that are present at birth and that are among the most common congenital malformations \[[@CR1], [@CR2]\]. It is estimated that the incidence of CHD is constant worldwide \[[@CR3], [@CR4]\], though data are rare for most African countries \[[@CR5], [@CR6]\]. The estimate of 8 cases per 1000 live births is widely accepted with variations between regions and countries due to genetic and environmental differences \[[@CR1], [@CR7]\].

Little is known about the prevalence of CHD in Tanzania and only very few studies have been published \[[@CR8], [@CR9]\]. But given a current birth rate of 2.1 million babies per year in the United Republic of Tanzania \[[@CR10]\] and considering an estimated incidence of 8 cases with CHD / 1000 live births would mean that up to 16.800 infants per year might be born with congenital heart disease.

Even less data are available on the prevalence of acquired heart diseases (AHD) in African children \[[@CR11]\]. Rheumatic heart disease (RHD) is still the leading cause of AHD and is remaining a public health concern in Sub-Saharan Africa affecting especially the young population \[[@CR11], [@CR12]\].

Both form of heart diseases together contribute substantially to morbidity and mortality during infancy and childhood in low- and middle-income countries \[[@CR6], [@CR13]\]. We therefore report a 7 years overview describing the spectrum of heart diseases diagnosed in a paediatric cardiac echocardiography clinic in the Lake Zone of Tanzania.

Methods {#Sec2}
=======

This hospital-based, retrospective study was conducted at the Bugando Medical Centre (BMC), Mwanza, Tanzania. BMC is one of four referral hospitals of mainland Tanzania serving for a population of approximately 14 million. The paediatric cardiac echocardiography clinic at BMC is performed twice per week, being the only clinic of its kind in the Lake Zone of Tanzania.

Patient data are recorded into a registration book and contain age, gender, type and severity of the heart disease as well as extracardiac malformations like Down syndrome (DS). Furthermore, a conclusion concerning the need for an intervention, e.g. surgery, is documented at the time of presentation. Children below 16 years of age who presented to the clinic for the first time and were diagnosed with an abnormal echocardiography study were included into the review. Cardiac consultation and echocardiography were performed by a paediatric cardiologist and by well-trained and supervised paediatricians (AZ, NM, TM). Echocardiography including two-dimensional-, colour-, pulse wave- and continuous wave-imaging was performed using two portable echocardiography machines, Sonosite M-Turbo and GE Loqic i. The leading lesion was recorded in cases of more than one cardiac lesion. The data were entered into Excel and then analysed by using simple descriptive statistics.

Quality control was ensured through visiting international cardiologists during cardiac missions and through intraoperative findings and diagnostic cardiac catheterizations done outside the country.

Results {#Sec3}
=======

Between September 2009 and August 2016, a total of 3982 children underwent cardiac evaluation and echocardiographic examination at the paediatric cardiac clinic of BMC. In 1830 cases (46.0%) pathologic findings were described. Out of these, 1371 (74.9%) patients had CHD, and 459 (25.1%) presented with AHD.

Congenital heart diseases {#Sec4}
-------------------------

53.9% of the patients with CHD were female and 19.3% of all cardiac patients presented with associated syndromes or extracardiac malformations. The most common associated syndrome was DS in 12.8% of the patients. Leading cardiac lesion was ventricular septal defect (VSD) in 358 patients (26.1%) followed by patent ductus arteriosus (PDA) in 318 patients (23.2%), which included also 51 premature infants admitted to the neonatal department of BMC. Most common cyanotic heart disease diagnosed at our clinic was Tetralogy of Fallot (ToF) in 10.1% of cases. The distribution and frequencies of CHD are shown in Table [1](#Tab1){ref-type="table"}. Table 1Distribution and relative frequencies of CHDDiagnosisNumber\
(*N* = 1371)%Ventricular septal defect (VSD)35826.1Patent ductus arteriosus (PDA)- PDA in premature infants- PDA in other children3185126723.2Atrioventricular septal defect (AVSD)- AVSD in DS1449810.5Tetralogy of Fallot (ToF)- ToF with pulmonary atresia1381610.1Secundum Atrial septal defect987.1Pulmonary stenosis584.2Truncus arteriosus503.8Double outlet right ventricle473.4Complex cyanotic CHD362.6Tricuspidatresia261.9Transposition of great arteries (TGA)- TGA with large VSD25151.8Others735.3

Only 208 (15.2%) out of 1371 patients with CHD were diagnosed within the first month of life, by 6 months of life diagnosis was reached in 42% of patients and close to 60% of patients were at least diagnosed within the first year of life. Approximately 40% of the children with VSD as the leading CHD were diagnosed within the first 6 months of life, whereas children with ToF as the most common cyanotic CHD were usually diagnosed later in life, only one third being diagnosed within the first year of life. The overall age distribution at diagnosis and age distribution for VSD, PDA (excluding the PDA in premature infants) and ToF are presented in graph 1: age distribution for VSD, PDA, ToF and overall.

At time of diagnosis approximately 60% of patients were judged to be in need of surgical or interventional treatment. Another 96 patients (7.0%) were in need of diagnostic catheterization to assess eligibility for surgery. The largest sub-groups of patients for diagnostic catheterization were children diagnosed with AVSD (42 cases) beyond the first year of life followed by ToF with pulmonary atresia (16 cases), VSD (16 cases) and complex cyanotic heart diseases (8 cases).

In 41 patients (3.0%) signs of severe pulmonary arterial hypertension (PAH) were present at time of diagnosis. The largest group of patients with severe PAH were those with Truncus arteriosus communis diagnosed beyond the first year of life (18 cases), followed by VSD (7 cases) diagnosed beyond 15 months of life and AVSD (6 cases) diagnosed at the age between 5 and 11 years of life. The remaining patients who presented with severe PAH were diagnosed with AP-window, TAPVR (total anomalous pulmonary venous return), PDA, DORV (double outlet right ventricle) and TGA with large VSD.

The distribution of cases with respect to need of further diagnostic assessment or treatment is shown in Table [2](#Tab2){ref-type="table"}. Table 2Need for further assessment or treatmentConditionNumber\
(*N* = 1371)%Mild CHD without need for surgery39228.6Indication for surgery / intervention given82560.1Diagnostic catheterization needed967.0Signs of severe pulmonary hypertension413.0Patient in critical clinical condition who died shortly after diagnosis171.2

Seven patients (0,5%) were diagnosed with CHD while they presented to our hospital with acute infective endocarditis or endarteritis and intracardiac or intraarterial vegetations were demonstrated by echocardiography. All 7 patients were already pre-treated with different antibiotic regimes before referral to our centre and therefore, blood cultures taken on admission at BMC didn't reveal the growth of any organism.

Nearly every fifth patient (19.3%) with congenital heart disease showed extracardiac malformations with DS being the leading associated syndrome. The distribution is depicted in Table [3](#Tab3){ref-type="table"}. Table 3extracardiac malformations / syndromesConditionNumber\
(*N* = 1371)%Down syndrome (DS)17612.8Syndromic features (not classified)352.6Anorectal malformation151.1Multiple malformation141.0Rubella syndrome120.8Others^a^130.9Total number of associated malformations / syndromes26519.3^a^Single cases of Omphalocele, Marfan Syndrome, Williams Syndrome, Turner Syndrome, connective tissue disease, Trisomy 18, missing sternum, ectopic Heart, and duodenal atresia

Acquired heart diseases {#Sec5}
-----------------------

Almost 50% of cases with AHD were RHD followed by dilated cardiomyopathy and pulmonary hypertension without an underlying structural heart disease. Table [4](#Tab4){ref-type="table"} is presenting the distribution and frequencies of AHD. Table 4Distribution and frequencies of AHDDiagnosisNumber\
(*n* = 459 cases)%Additional informationRheumatic Heart disease (RHD)22849.7Dilated Cardiomyopathy (DCM)7416.116 cases of HIVPulmonary Hypertension (PAH)4810.54 cases of SchistosomiasisPericardial effusion (PE)337.210 cases of TBOther cardiomyopathies296.310 cases of malignanciesPersistent pulmonary hypertension of the newborn (PPHN)275.9Endomyocardial Fibrosis (EMF)204.3

49.6% of the patients with RHD were female and the majority of patients diagnosed with RHD presented with isolated mitral valve regurgitation (69.3%), whereas 8.3% showed multivalvular disease followed by isolated aortic valve regurgitation (7.5%) and combined mitral valve regurgitation and mitral valve stenosis (6.6%)

At time of diagnosis most patients presented with advanced RHD and indication for surgery (valve repair or valve replacement) was given in 197 out of 228 cases (86.4%).

Discussion {#Sec6}
==========

This is the first review on the spectrum of heart diseases in children in Tanzania and reports the data of a single centre. Out of 3982 patients who underwent cardiac evaluation and echocardiographic examination during the study period of 7 years 1830 (46%) presented with pathologic findings. Majority of patients (74.9%) were diagnosed with CHD. The overall distribution of heart diseases in congenital and acquired cases corresponds well with the findings of a comparable study in Cameroon, where out of 1666 cardiac patients, 73.8% presented with CHD and 25.8% with AHD \[[@CR14]\].

Assessing the distribution of CHD in our review, VSD was the most common type, which is consistent with the results of two meta-analyses \[[@CR1], [@CR4]\] and a literature review \[[@CR15]\] for the worldwide prevalence of this heart defect. Though most of the studies done in developing countries demonstrated even a higher prevalence of VSD ranging from 30 to 58% \[[@CR14], [@CR16]--[@CR18]\] compared to our result of 26.1%.

As characteristic for countries with low resources and limited access to cardiac surgery Tetralogy of Fallot (ToF) is the leading cyanotic heart disease and the frequency is higher than documented in developed countries \[[@CR14], [@CR17]--[@CR19]\]. Children with ToF do not present with heart failure, but with progressing signs of chronic cyanosis (e.g. finger clubbing) and frequent squatting. Many of them show a naturally balanced pathophysiology and survive without intervention whereas infants suffering from other cyanotic heart diseases might die early and even undiagnosed \[[@CR17], [@CR20]\]. This is also supported by our findings of diagnosis specific age distribution among children with VSD, PDA and ToF. Approximately 60% of children born with VSD or PDA were diagnosed within the first year of life, whereas the majority of children suffering from ToF seen in our centre (65.9%) was diagnosed beyond the first year of life.

Interestingly, the frequency of AVSD (10.5%) in our study was higher than in any other African study. In general, the frequency of AVSD in studies from developing countries is reported to be between 3.5 and 8.8% \[[@CR17], [@CR21], [@CR22]\]. The high prevalence of AVSD, mainly in association with DS, was a constant finding throughout the consecutive years. The prevalence of DS in Tanzania is not known, but studies from Nigeria and South Africa have stated that the prevalence of DS in Sub Saharan Africa is exceeding the reported prevalence of 1 in 750 live births in western countries \[[@CR23], [@CR24]\]. This may be influenced by prenatal diagnosis and termination of pregnancy in the western countries \[[@CR25]\]. Furthermore, a recent study from Nigeria examined the prevalence of CHD in children with DS and found a prevalence of 75%, which is significantly higher than reported by others \[[@CR26]\].

Overall, the rate of associated extracardiac malformations corresponds well with the findings of other studies \[[@CR25], [@CR27], [@CR28]\].

RHD presented as the leading cause of AHD in children in our study similar to what is consistently reported worldwide \[[@CR13]\]. It is furthermore very likely that the condition is widely underreported in our review as the vast majority of patients was diagnosed with advanced findings and we didn't detect any subclinical RHD as reported in other reviews \[[@CR11]\].

Echocardiography is a valuable diagnostic tool as it is non-invasive and cost-effective. The widespread use of it should be enhanced with more paediatricians being trained in this technique, especially in settings with low resources. In a first step paediatricians trained and supervised by paediatric cardiologists to perform echocardiography in the rural areas with mobile echocardiography equipment has to be the goal to diagnose CHDs and AHDs in a large number and in a reasonable time.

Limitations of the study: This study is a single centre, hospital based review and not a community based study. Therefore, the study does not provide information on the prevalence of heart diseases in the general paediatric population of Tanzania. Furthermore, it is a retrospective review of the echocardiography registry, which contains some incomplete data or missing information. Diagnostic tools like cardiac catheterization or cardiac CT scan were not available in Tanzania during the time of the study period so that cardiac diagnoses were mainly based on echocardiographic findings. Long-term outcome of the patients is incomplete as a substantial number of patients were lost to follow-up.

Conclusion {#Sec7}
==========

The spectrum of congenital and acquired heart diseases presenting to the paediatric cardiac echocardiography clinic of BMC is corresponding well to the findings reported in other countries from the African continent.

The majority of children with heart disease presenting to our clinic is in need of surgical or interventional treatment, which is not readily available. Furthermore, diagnosis is often delayed and as a consequence a significant number of patients show severe complications and an advanced stage of the heart disease on initial diagnosis. Untreated heart diseases contribute substantially to morbidity and mortality during infancy and childhood. Adequate local cardiac services should be established and strengthened.

Echocardiography is a valuable diagnostic tool as it is non-invasive and cost-effective. The widespread use of it should be enhanced with more paediatricians being trained in this technique, especially in settings with low resources.

Children diagnosed with CHD should be carefully examined for extracardiac malformations due to the significant association between CHD and extracardiac malformations.

All children with DS should routinely receive a cardiac examination because of the high association of CHD. A further study would be needed to determine the prevalence of CHD in children with DS in Tanzania.

RHDs are certainly underreported as most patients were diagnosed with advanced findings and no cases of subclinical RHD were detected. Further population based prevalence studies are required to determine the real burden of this disease and to guide preventive programmes.
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